Evaluation of a new invagination technique of pancreatojejunostomy, the most delicate anastomoses: technical details and results of a personal series
收藏资源简介:
The treatment of pancreatic stump is a critical step of pancreaticoduodenectomy (PD) because leaks from this anastomosis incur major morbidity and mortality. We describe technical details of a personal invagination pancreatojejunostomy (piPJ) and report on its safety. From October 2008 to October 2016, 401 pancreatic resections were performed, of which 187 were PD. A new invagination pancreaticojejunostomy (PJ) was introduced in November 2010 and used in 84 consecutive patients. Data were retrieved from a prospectively collected Institutional database, and used for present retrospective evaluation of the piPJ. Data were retrieved from a prospectively collected Institutional database, and used for present retrospective evaluation of the piPJ. ISGPFc POPF occurred in 14/84 (17%): grade A in 9/84 (11%), grade B in 4/84 (5%) and grade C in 1/84 (1.2%). On the ISGPSc, POPF rate averaged 6%: grade B in 4/84 (5%) and grade C in 1/84 (1.2%). POPF rate associated with high FRS was 20.0%/7% (ISGPFc/ISGPSc). With low and intermediate FRS, POPFs were 6%/0% (ISGPFc/ISGPSc) and 21%/8% (ISGPFc/ISGPSc) respectively. Re-operation rate was 3.6% (3/84). In-hospital mortality rate was 2.4% (2/84) and specific mortality rate for POPF was 1.2% (1/84).
胰残端处理是胰十二指肠切除术(pancreaticoduodenectomy, PD)的关键步骤,因该吻合口漏可引发严重并发症与死亡风险。本文详述了个人套入式胰肠吻合术(personal invagination pancreatojejunostomy, piPJ)的技术细节,并报告了其临床安全性。2008年10月至2016年10月期间,本中心共完成401例胰腺切除术,其中187例为胰十二指肠切除术。2010年11月起引入新型套入式胰肠吻合术(pancreaticojejunostomy, PJ),并连续应用于84例患者。数据来自前瞻性收集的机构数据库,用于本次针对piPJ的回顾性评估。数据来自前瞻性收集的机构数据库,用于本次针对piPJ的回顾性评估。按国际胰腺外科研究小组分类(ISGPFc),术后胰瘘(postoperative pancreatic fistula, POPF)发生率为14/84(17%):其中A级9/84(11%)、B级4/84(5%)、C级1/84(1.2%)。按国际胰腺外科研究小组分类(ISGPSc),术后胰瘘发生率平均为6%:其中B级4/84(5%)、C级1/84(1.2%)。高胰瘘风险评分(FRS)患者的术后胰瘘发生率为20.0%/7%(ISGPFc/ISGPSc)。低风险与中风险FRS患者的术后胰瘘发生率分别为6%/0%(ISGPFc/ISGPSc)与21%/8%(ISGPFc/ISGPSc)。再手术率为3.6%(3/84)。院内死亡率为2.4%(2/84),因术后胰瘘导致的特异性死亡率为1.2%(1/84)。




